The largest database of trusted experimental protocols

Crispr rna crrna

Manufactured by Integrated DNA Technologies
Sourced in United States

CRISPR RNA (crRNA) is a key component of the CRISPR-Cas9 gene editing system. It serves as a guide that directs the Cas9 enzyme to the target DNA sequence for cleavage.

Automatically generated - may contain errors

5 protocols using crispr rna crrna

1

CRISPR-Mediated Deletion of KCNJ13 in hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
By utilizing CRISPRdirect (https://crispr.dbcls.jp),16 (link) more than two candidate target sequences for guide RNA (gRNA) were found in the human KCNJ13 gene (NM_001172416) obtained from the Ensemble database (http://asia.ensembl.org/index.html). To ensure specificity, the hit sequence showing one (“1”) in the column “20 mer + PAM,” which indicates a perfect match with the intended target site, was selected. Only RFX1 was listed as a candidate off-target gene. To delete most of the KCNJ13 gene, two target sequences were determined; one was localized to approximately 100 bases downstream of the start codon, and the other was in the 3′UTR (Fig. 1A). Two CRISPR RNA (crRNA) complementary to the target sequences and the trans-activating CRISPR RNA (tracrRNA) were obtained from Integrated DNA Technologies, Inc. (Coralville, IA, USA). The crRNA and tracrRNA were each annealed to construct gRNA according to the manufacturer's instructions. We performed gene editing of hiPSCs according to previous studies17 (link),18 (link) (see Supplementary Methods).
+ Open protocol
+ Expand
2

Cas12a-based ELISA for CXCL9 Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
EnGen® Lba Cas12a (Cpf1) and buffer for Cas12a (NEB buffer 2.1) were purchased from New England Biolabs (Ipswich, MA). CRISPR RNA (crRNA) and FQ reporter for Cas12a were synthesized by Integrated DNA Technologies (Coralville, IA). Streptavidin was purchased from Promega (Madison, WI). ELISA kits, which has capture and detection antibodies, target protein (recombinant human CXCL9 or CXCLl), and buffers was purchased from R&D Systems (Minneapolis, MN). Synthetic urine was purchased from Sigma-Aldrich (St. Louis, MO) (Table S1). All solutions were prepared with purified water by a Milli-Q Purification System from Millipore (Burlington, MA).
+ Open protocol
+ Expand
3

Generation of ApoE Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
ApoE knockout mice were generated in zygotes from homozygous Rag2tm1.1FlvCsf1tm1(CSF1)FlvIl2rgtm1.1FlvApptm3.1Tcs mice using CRISPR–Cas9 technology by targeting exon 4 of the mouse ApoE gene. The RNA guide 5′-CCTCGTTGCGGTACTGCCCGAGT-3′ was selected using the CRISPOR web tool. Ribonucleoproteins containing 0.3 μM purified Cas9HiFi protein (Integrated DNA Technologies), 0.3 μM CRISPR RNA (crRNA) and 0.3 μM trans-activating crRNA (Integrated DNA Technologies) were injected into the pronucleus of 72 embryos by microinjection in the Mouse Expertise Unit of KU Leuven. Two candidate pups were identified by PCR analysis with several primer combinations. One founder was selected for breeding and an allele with a chromosomal deletion of 335 base pairs (bp) (corresponding to 148 bp of intronic sequence and the first 187 bp of exon 4 sequence) (Extended Data Fig. 4) was selected to establish the colony. The founder mouse was backcrossed over two generations before a homozygous colony was established, which was designated AppNL-G-FApoE−/−. The strain was maintained on the original C57Bl6J:BalbC background. Standard genotyping for the ApoE allele was performed by PCR with primers 5′-GCTCCCAAGTCACACAAGAA-3′ and 5′-CTCACGGATGGCACTCAC-3′, resulting in a 755-bp amplicon for the WT allele and a 420-bp amplicon for the ApoE knockout allele.
+ Open protocol
+ Expand
4

Otr Knockout in Dental Pulp Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We knocked out Otr in dental pulp cells using the Alt-R CRISPR-Cas9 System (Integrated DNA Technology, Coralville, IA) according to the manufacturer's instructions.
The CRISPR RNA (crRNA) targeting the sequences of Otr (Locus chr 4, position; -144415980: 5'-CGGGCCACCACAACGCAA CG-3') was purchased from Integrated DNA Technology, and the RNP (Cas9 and gRNA ribonucleoprotein) complex was transfected into dental pulp cells using a cationic lipid delivery system (RNAiMAX, Thermo Fisher Scientific) according to the manufacturer's instructions. The negative control crRNA is designed not to recognize any sequence in the rat genome and was used in a negative control RNP complex to transfect dental pulp cells. The Otr knockout cells were cultured with or without OT (50 nmol/L) up to day 21.
+ Open protocol
+ Expand
5

CRISPR crRNA Target Sequences and Efficiency

Check if the same lab product or an alternative is used in the 5 most similar protocols
The crispr RNA (crRNA) obtained from Integrated DNA Technologies (IDT) with the following target sequence were used: aifm1 crRNA: 5′-CTTGCCAAGGTGGAGAACGG-3′, parp1 crRNA: 5′-TGGATTTACTGACCTCCGCT-3′, nampta 5′-AGTAAAGAGCACATTTCCCCG-3′; namptb 5′-GGAGTAGACTTTATTTATAT-3′; nox1 crRNA: CAAGCTGGTGGCCTACATGA; nox4 crRNA: TTCGCTTGTGTCCTTCAAGC and nox5 crRNA: GAGGTCATGGAAAATCTCAC. They were resuspended in duplex buffer at 100 μM, and 1 μl was incubated with 1 μl of 100 μM trans-activating CRISPR RNA (tracrRNA) at 95°C for 5 minutes and then 5 minutes at room temperature (RT) to form the complex. Then, the mix was diluted with 1.40 μl of duplex buffer. One μl of this complex was mixed with 0.20 μl of recombinant Cas-9 (10 mg/ml), 0.25 μl of phenol red, and 2.55 μl of duplex buffer. The efficiency of each crRNA was determined by the TIDE webtool (https://tide.nki.nl/) [56 (link)]. Crispant larvae of 3 dpf were used in all studies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!